🇺🇸 FDA
Pipeline program

Multi-component intervention package

CAMS&PUMC-IEC-2024-040

Unknown other completed

Quick answer

Multi-component intervention package for Multimorbidity is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Multimorbidity
Phase
Unknown
Modality
other
Status
completed

Clinical trials